Молекулярно-генетические девиации и акушерская патология

1. Romero R. Prenatal medicine: The child is the father of the man. 1996. J Matern Fetal Neonatal Med. 2009; 22(8): 636–9. doi: 10.1080/14767050902784171.
2. Uzun A., Schuster J., McGonnigal B., Schorl C., Dewan A., Padbury J. Targeted sequencing and meta-analysis of preterm birth. PLoS One. 2016; 11(5): e0155021. doi: 10.1371/journal.pone.0155021
3. Strauss J.F., Romero R., Gomez-Lopez N., Haymond-Thornburg H., Modi B. P., Teves M.E., et al. Spontaneous preterm birth: advances toward the discovery of genetic predisposition. Am J Obstet Gynecol. 2018; 218(3): 294–314. doi: 10.1016/j.ajog.2017.12.009.
4. Чурносов М.И., Кокорина О.С. Генетические исследования хронической плацентарной недостаточности и синдрома задержки роста плода. Российский вестник акушера-гинеколога. 2014; 1: 27–32.
5. Di Renzo G.C. The great obstetrical syndromes. J Matern Fetal Neonatal Med. 2009; 22: 633–635. doi: 10.1080/14767050902866804.
6. Brosens I., Pijnenborg R., Vervruysse L., Romero R. The «Great obstetrical syndromes» are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011; 204(3): 193–201. doi: 10.1016/j.ajog.2010.08.009.
7. Mastrolia S.A., Mazor M., Loverro G., Klaitman V., Erez O. Placental vascular pathology and increased thrombin generation as mechanisms of desease in obstetrical syndromes. PerrJ. 2014; 18(2): e653. doi: 10.7717/peerj.653

8. Тезиков Ю.В., Липатов И.С., Фролова Н.А., Кутузова О.А., Приходько А.В. Методология профилактики больших акушерских синдромов. Здоровье женщины. 2017; 10(126): 19.

9. Цахилова С.Г., Акуленко Л.В., Кузнецов В.М., Балиос Л.В., Скобенников А.Ю., Созаева Л.Г., и др. Генетические предикторы преэклампсии (обзор литературы). Проблемы репродукции. 2017; 1: 110–4.

10. McPherson J.A., Manuck T.A. Genomics of preterm birth-evidence of association and evolving investigations. Am J Perinatol; 2016; 33(3): 222–8. doi: 10.1055/s-0035-1571144
11. Dossenbach-Glaninger A., van Trotsenburg M., Oberkanins C., Atamaniuk J. Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration. J Clin Lab Anal. 2013; 27(6): 444–9.doi: 10.1002/jcla.21626.
12. Kamali M., Hantoushzadeh S., Borna S., Neamatzadeh Y., Mazaheri M., Noori-Shadkam M., et al. Associateon between trombophilic genes polymorphisms and recurrent pregnancy loss susceptibility in the Iranian population: a systematic review and meta-analysis. Iran Biomed J. 2017; 22(222): 78–89. doi: 10.22034/ibj.22.2.78
13. Shi X., Xie X., Jia Y., Li S. Maternal genetic polymorphisms and unexplained recurrent miscarriage: a systematic review and meta-analysis. Clin Genet. 2017; 91(2): 265–84. doi: 10.1111/cge.12910
14. Lenz B., Samardzija M., Drenjacevic D., Zibar D., Samardzija M., Milostic-Srb A. The investigation of hereditary and acquired thrombophilia risk factors in the development of complications in pregnancy in Croatian women. J Matern Fetal Neonatal Med. 2016; 29(2): 264–9. doi: 10.3109/14767058.2014.998189.
15. Li X., Liu Y., Zhang R., Tan J., Chen L., Liu Y. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss. Med Sci Monit. 2015; 21: 1051–6. doi: 10.12659/MSM.892898.
16. Giannkou K., Evangelou E., Papatheodorou S.I. Genetic and non-genetic risk factors for pre-eclampsia: umbrella review of systematic reviews and meta-analyses of observational studies. Ultrasound Obstet Gynecol. 2018; 51(6): 720–30. doi: 10.1002/uog.18959.
17. Pileri P., Franchi F., Cetin I., Mando C., Antonazzo P., Ibrahim B., et al. Maternal and fetal thrombophilia in intrauterine growth restriction in the presence or absence of maternal hypertensive disease. Reprod Sci. 2010; 17(9): 844–8. doi: 10.1177/1933719110371516.
18. Barlic M., Seremak-Mrozikiewicz A., Drews K., Klejewski A., Kurzawinska G., Lowicki Z., et al. Correlarion between factor VII and PAI-1 genetic variants and recurrent miscarriage. Ginekol Pol. 2016; 87(7): 504–9. doi: 10.5603/GP.2016.0034
19. Jackson R.A., Nguyan M.L., Barrett A.N., Tan Y.Y., Choolani M.A., Chen E.S. Synthetic combinations of missense polymorphic genetic changes underlying Down Syndrome susceptibility. Cell Mol Life Sci. 2016; 73(21): 4001–17. doi:10.1007/s00018-016-2276-0
20. Wu H., Zhu P., Geng X., Liu Z., Cui L., Gao Z., et al. Genetic polymorphism of MTHFR C677T with preterm birth and low birth weight susceptibility: a meta-analysis. Arch Gynecol Obstet. 2017; 295(5): 1105–11. doi:10.1007/s00404-017-4322-z
21. Fang Q., Jiang Y., Liu Z., Zhang Z., Zgang T. Systematic review and meta-analysis of the associations between maternal methylentetrahydrofolate reductase polymorphisms and preterm delivery. J obstet Gynaecol Res. 2018; 44(4): 663–72. doi:10.1186/s13098-019-0451-9
22. Nan Y., Li H. MTHFR genetic polymorphism increases the risk of preterm delivery. Int J Clin Exp Pathol. 2015; 8(6): 7397–402. PMCID:PMC4525976
23. Chedraui P., Andrade M.E., Salazar-Pousada D., Escobar G.S., Hidalgo L., Ramirez C., et al. Polymorphisms of the methylentetrahydrofolate reductase gene (C677T and A1298C) in the placenta of pregnancies complicated with preeclampsia. Gynecol Endocrinol. 2015; 31(7): 569–72. doi: 10.3109/09513590.2015.1031104.
24. Chen J., Chen L., Zhu L.H., Zhang S.T., Wu Y.L. Assotiation of methylentetrahydrofolate reductase (MTHFR) C677T polymorphism with preterm delivery and placental abruption: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2016; 95(2): 157–65. doi:10.1007/s10815-019-01473-2
25. Hwang K.R., Choi Y.M., Kim J.J., Lee S.K., Yang K.M., Palk E.S., et al. Methylentetrahydrofolate reductase polymorphisms and risk of recurrent pregnancy loss: a case control study. J Korean Med Sci. 2017; 32(12): 2029–34. doi:10.3346/jkms.2017.32.12.2029
26. Nowak I., Bylinska A., Wilcznska A. The methylentetrahydrofolate reductase c.c. 677 C>T and c.c. 1298 A>C polymorphisms in reproducrive failures: experience from RSA and RIF study on a polish population. PloS One. 2017; 12(10): e0186022. doi:10.1371/journal.pone.0186022

27. Татарский П.Ф., Кучеренко А.М., Хажиленко К.Г., Зинченко В.М., Ильин И.Е., Лившиц Л.А. Исследования возможной роли полиморфизма генов системы детоксикации и коагуляции крови в патогенезе потери беременности. Biopolimers and cell. 2011; 27 (3): 214–20.

28. Баранов В.С., ред. Генетический паспорт – основа индивидуальной и предиктивной медицины. CПб.: ООО «Издательство Н-Л», 2009. 528 c.

29. Groten T., Schleussner E., Lehmann T., et al. eNOSI4 and EPHX1 polymorphisms affect maternal susceptibility to preeclampsia: analysis of five polymorphisms predisposing to cardiovascular disease in 279 Caucasian and 241 African women. Arch Gynecol Obstet. 2014; 289 (3): 581–93. doi: 10.1007/s00404-013-2991-9.
30. Sandoval-Carrillo A., Aguilar-Duran M., Vázquez-Alaniz F., Castellanos-Juárez F.X., Barraza-Salas M., Sierra-Campos E., et al. Polymorphisms in the GSTT1 and GSTM1 genes are associated with increased risk of preeclampsia in the Mexican mestizo population. Genet. Mol. Res. 2014; 13(1): 2160–5. doi: 10.4238/2014.January.17.3

31. Будюхина О.А., Барановская Е.И., Левданский О.Д., Даниленко Н.Г. Полиморфизм генов глутатион-S-трансфераз у пациенток с хронической фетоплацентарной недостаточностью. Здравоохранение. 2010; 6: 14–5.

32. Фетисова И.Н., Панова И.А., Малышкина А.И. Полиморфизм генов ренин-ангиотензин-альдостероновой системы у женщин с гипертензивными расстройствами при беременности. Таврический медико-биологический вестник. 2017; 20 (2): 160–5.

33. Li Y., Zhu M., Hu R., Yan W. The effects of gene polymorphisms in angiotensin II receptors on pregnancy-induced hypertension and preeclampsia: a systematic rewiew and meta-analysis. Hypertens Pregnancy. 2015, 34(2): 241–60. doi: 10.3109/10641955.2015.1009543.
34. Capece A., Vasiava O., Meher S., Alfirevic Z., Alfirevic A. Pathway analysis of genetic factors associated with spontaneus preterm birth and pre-labor preterm rupture of membranes. PLoS One. 2014. 9(9): e108578. doi: 10.1371/journal.pone.0108578
35. Saboori S., Noormohammadi Z., Zare-Karizi S. Genetic variation in vascular endothelial growth factor gene and its association with recurrent spontaneous abortion. Bratisl Lek Listy. 2016; 117(2): 80–6. doi: 10.4149/BLL_2016_016
36. Li Y., Yao C.J., Tao F.B., Luo C.M., Cao Y., Su-Juan Z. Association between maternal tumor necrosis factor-α G308A polymorphism and interferon-γ A874T polymorphism and risk of preterm birth: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2015 Jul; 190: 11–9. doi: 10.1016/j.ejogrb.2015.04.003
37. Zhou L., Cheng L., He Y., Gu Y., Wang Y., Wang C. Association of gene polymorphisms of FV, FII, MTHFR, Serpine1, CTL4A, IL10, and TNF alpha with pre-eclampsia in Chinese women. Inflamm Res. 2016; 65(9): 717–24. doi:10.1007/s00011-016-0953-y
38. Pereza N., Ostojic S., Kapovic M., Peterlin B. Systematic review and meta-analysis of genetic assotiation studies in idiopathic recurrent spontaneous abortion. Fertil Steril. 2017; 107(1): 150–9. doi: 10.1016/j.rbmo.2015.11.003
39. Procopciuc L.M., Caracostea G., Zaharie G., Stamatian F. Maternal/newborn VEGF-C936T interaction and its influence on the risk, severity and prognosis of preeclampsia, as well as on the maternal angiogenic profile. J matern Fetal Neonatal Med. 2014; 27(17): 1754–60. doi: 10.3109/14767058.2014.942625.
40. Garza-Veloz I., Castruita-De la Rosa C., Cortes-Flores R., Martinez-Gaytan V., Rivera-Munoz J.E., Garcia-Mayorga E.A., et al. No association between polymorphisms/haplotypes of the vascular endothelial growth factor gene and preeclampsia. BMC Pregnancy Childbirth. 2011; 16(11): 35. doi: 10.1186/1471-2393-11-35

41. Глотов А.С., Вашукова Е.С., Глотов О.С., Насыхова Ю.А., Мазур А.М., Курилов Р.В., и др. Исследование популяционных частот полиморфизма генов, ассоциированных с гестозом. Экологическая генетика. 2013; 11(7): 91–100.

42. Рыжкова О.П., Кардымон О.Л., Прохорчук Е.Б., Коновалов Ф.А., Масленников А.Б., Степанов В.А., и др. Руководство по интерпретации данных, полученных методами массового параллельного секвенирования (MPS). Медицинская генетика. 2017; 16(7): 4–17.

43. Morgan L. Update of genetics of preeclampsia. Pregnancy Hypertens. 2013; 3(2): 59–60. doi: 10.1016/j.preghy.2013.04.009
44. Workalemahu T., Enquobahrie D.A, Gelaye B., et al. Genetic variations and risk of placental abruption: A genome-wide association study and meta-analysis of genome-wide association studies. Placenta. 2018; 66: 8–16. doi:10.1016/j.placenta.2018.04.008
45. Kaartokallio T., Wang J., Heinonen S. , Kajantie E., Kivinen K., Pouta A., et al. Exome sequencing in pooled DNA samples to identify maternal pre-eclampsia risk. Sci Rep. 2016; 6: 29085. doi: 10.1038/srep29085.
46. Johnson M., Loset M., Brennecke S., Brennecke S.P., Peralta J., Dyer T.D., et al. Exome sequencing identifies likely functional variants influencing preeclampsia and CVD risk. Pregnancy Hypertens. 2012; 2(3): 203–4. doi: 10.1016/j.preghy.2012.04.050
47. Hansen A.T., Bernth Jensen J.M., Hvas A.V., Christiansen M. The genetic component of preeclampsia: a whole-exome sequencing study. PLos One. 2018; 13(5): e0197217. doi:10.1371/journal.pone.0197217
48. Modi B.P., Teves M.E., Pearson L.N. Parikh H.I., Chaemsaithong P., Sheth N.U., et al. Rare mutations and potencially damaging missense variants in genes encoding fibrilar collagens and proteins involved in their production are camdidates for risk for preterm premature rupture of membranes. PLoS One. 2017; 12(3): e0174356. doi: 10.1371/journal.pone.0174356.
49. Modi B.P., Teves M.E., Pearson L.N. Parikh H.I., Haymond-Thornburg H., Tucker J.L. et al. et al. Mutetions in fetal genes involved in innate immunity and host defense against microbes increase risk of preterm premature rupture of membranes (PPROM). Mol Genet Genomic Med. 2017; 5(6): 720–9. doi: 10.1002/mgg3.330

Поступила 04.03.2019

Принята в печать 19.04.2019